The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 10,901–11,000 of 31,469
Taşkapan, M. Ç., Taşkapan, H., Şahin, İ., Keskin, L., Atmaca, H., & Özyalın, F. (2007) · Renal Failure · doi:10.1080/08860220601095827 · Cited by 32
Wang, F., Ma, X., Zhou, M., Pan, X., Ni, J., Gao, M., Lu, Z., Hang, J., Bao, Y., & Jia, W. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-56 · Cited by 32
Ma, X., Hu, X., Zhou, J., Hao, Y., Luo, Y., Lu, Z., Bao, Y., & Jia, W. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0166-z · Cited by 32
Krishnaveni, G. V., Veena, S. R., Wills, A. K., Hill, J. C., Karat, S. C., & Fall, C. H. D. (2010) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174410000498 · Cited by 32
Petry, T. B. Z., Fabbrini, E., Otoch, J. P., Carmona, M. A., Caravatto, P. P. D. P., Salles, J. E. N., Sarian, T., Correa, J. L., Schiavon, C. A., Patterson, B. W., et al. (2015) · Obesity · doi:10.1002/oby.21190 · Cited by 35
Siqueira-Catania, A., Cezaretto, A., de Barros, C. R., Salvador, E. P., dos Santos, T. C., & Ferreira, S. R. G. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-21 · Cited by 32
Ryan, K. J., Casas, J. M. S., Mash, L. E., McLellan, S. L., Lloyd, L., Stinear, J. W., Plank, L. D., & Collins, M. G. (2014) · BMC Nephrology · doi:10.1186/1471-2369-15-148 · Cited by 32
Schmitt, F., Riquin, É., Beaumesnil, M., Dinomais, M., Topart, P. A., Weil, D., Malka, J., Coutant, R., Podevin, G., & Bouhours‐Nouet, N. (2015) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2015.08.057 · Cited by 32
Johnson‐Down, L., Labonté, M., Martin, I. D., Tsuji, L. J. S., Nieboer, E., Dewailly, É., Egeland, G. M., & Lucas, M. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.08.002 · Cited by 39
Khadgawat, R., Thomas, T., Gahlot, M., Tandon, N., Tangpricha, V., Khandelwal, D., & Gupta, N. (2012) · International Journal of Endocrinology · doi:10.1155/2012/173581 · Cited by 32
Lim, S. K., Choi, H. J., Shin, H., Khang, A. R., Kang, S. M., Yoon, J. W., Choi, S. H., Jeong, I. K., Cho, S., Park, K. S., et al. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.05.054 · Cited by 32
Khalyfa, A., Gharib, S. A., Kim, J., Capdevila, Ó. S., Gozal, D., Bhattacharjee, R., Hegazi, M., & Gozal, D. (2011) · SLEEP · doi:10.1093/sleep/34.2.153 · Cited by 32
Does Inflammation Mediate the Association Between Obesity and Insulin Resistance?
Adabimohazab, R., Garfinkel, A. C., Milam, E. C., Frosch, O. H., Mangone, A., & Convit, A. J. (2016) · Inflammation · doi:10.1007/s10753-016-0329-z · Cited by 32
Wang, N., Qin, L., Han, B., Chen, Y., Zhu, C., Chen, Y., Xia, F., Lu, M., Meng, Y., Guo, Y., et al. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13271 · Cited by 32
Plasma Incretin Levels and Dipeptidyl Peptidase-4 Activity in Patients with Obstructive Sleep Apnea
Matsumoto, T., Harada, N., Azuma, M., Chihara, Y., Murase, K., Tachikawa, R., Minami, T., Hamada, S., Tanizawa, K., Inouchi, M., et al. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201510-697oc · Cited by 33
Silveira, J. S., Clapauch, R., de Souza, M. D. G. C., & Bouskela, E. (2016) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000641 · Cited by 32
Ancient Wheat Diet Delays Diabetes Development in a Type 2 Diabetes Animal Model
Thorup, A. C. S., Gregersen, S., & Jeppesen, P. B. (2014) · The Review of Diabetic Studies · doi:10.1900/rds.2014.11.245 · Cited by 35
Effect of Slow Wave Sleep Disruption on Metabolic Parameters in Adolescents
Shaw, N. D., McHill, A. W., Schiavon, M., Kangarloo, T., Mankowski, P. W., Cobelli, C., Klerman, E. B., & Hall, J. E. (2016) · SLEEP · doi:10.5665/sleep.6028 · Cited by 33
Brutsaert, E. F., Biggs, M. L., Delaney, J. A., Djoussé, L., Gottdiener, J. S., Ix, J. H., Kim, F., Mukamal, K. J., Siscovick, D. S., Tracy, R. P., et al. (2016) · Metabolism · doi:10.1016/j.metabol.2016.06.002 · Cited by 32
Fiorentino, T. V., Andreozzi, F., Mannino, G. C., Pedace, E., Perticone, M., Sciacqua, A., Perticone, F., & Sesti, G. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1856 · Cited by 36
Costa, S. M. R., ISGANAITIS, E. M., Matthews, T. J., Hughes, K. J., Daher, G., Dreyfuss, J. M., da Silva, G. A. P., & Patti, M. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.142 · Cited by 32
Serum 25(OH)D and adipokines levels in people with abdominal obesity
Каронова, Т. Л., Belyaeva, О. D., Jude, E. B., Tsiberkin, A. I., Андреева, А., Grineva, E. N., & Płudowski, P. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.09.005 · Cited by 32
Kwon, S. S., Lee, S., Lee, Y., Lim, J., & Kim, J. (2016) · Clinical Endocrinology · doi:10.1111/cen.13233 · Cited by 33
Ida, S., Murata, K., Betou, K., Kobayashi, C., Ishihara, Y., Imataka, K., Uchida, A., Monguchi, K., Kaneko, R., Fujiwara, R., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0468-4 · Cited by 32
Keapai, W., Apichai, S., Amornlerdpison, D., & Lailerd, N. (2016) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2016.20.6.581 · Cited by 32
Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer’s Disease Outcomes
McLimans, K. E., Willette, A. A., & Initiative, A. D. N. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160891 · Cited by 33
Obesity as a Risk Factor for Prostatic Enlargement: A Retrospective Cohort Study in Korea
Jung, J. H., Ahn, S. V., Song, J. M., et al. (2016) · International Neurourology Journal · doi:10.5213/inj.1632584.292 · Cited by 32
Sleep quality among elderly high-altitude dwellers in Ladakh
Sakamoto, R., Okumiya, K., Norboo, T., Norboo, T., Yamaguchi, T., Nose, M., TAKEDA, S., Tsukihara, T., Ishikawa, M., Nakajima, S., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.12.043 · Cited by 32
de la Escalera, L. M., Kyrou, I., Vrbíková, J., Hainer, V., Šrámková, P., Fried, M., Piya, M. K., Kumar, S., Tripathi, G., & McTernan, P. G. (2017) · BMC Medicine · doi:10.1186/s12916-017-0797-5 · Cited by 32
Sun, X., Zhang, Z., Ning, H., Sun, H., & Ji, X. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-9958-7 · Cited by 33
dos Santos, K. C., Bueno, B. G., Pereira, L. F., et al. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/6418048 · Cited by 32
Toussirot, É., Michel, F., Béreau, M., Dehecq, B., Gaugler, B., Wendling, D., Grandclément, É., Saas, P., & Dumoulin, G. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3789-0 · Cited by 32
The association between muscle mass deficits and arterial stiffness in middle-aged men
Im, I. J., Choi, H. J., Jeong, S. M., Kim, H. J., Son, J. S., & Oh, H.-J. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.10.002 · Cited by 32
Huang, Y., Ye, T.-T., Liu, C.-X., Wang, L., Chen, Y., & Dong, Y. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0222-2 · Cited by 32
Takamura, Y., Nomura, M., UCHIYAMA, A., & Fujita, S. (2017) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.63.339 · Cited by 32
Kawarabayashi, R., Motoyama, K., Nakamura, M., Yamazaki, Y., Morioka, T., Mori, K., Fukumoto, S., Imanishi, Y., Shioi, A., Shoji, T., et al. (2017) · Journal of Diabetes Research · doi:10.1155/2017/6549242 · Cited by 32
Chinapaw, M. J. M., Klakk, H., Møller, N. C., Andersen, L. B., Altenburg, T. M., & Wedderkopp, N. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0063-8 · Cited by 32
Cardiometabolic Risk Factors at 5 Years After Omega-3 Fatty Acid Supplementation in Infancy
See, V. H. L., Mori, T. A., Prescott, S. L., Beilin, L. J., Burrows, S., & Huang, R. (2018) · PEDIATRICS · doi:10.1542/peds.2016-2623 · Cited by 32
Iguacel, I., Michels, N., Ahrens, W., Bammann, K., Eiben, G., Fernández-Alvira, J. M., Mårild, S., Molnár, D., Reisch, L. A., Russo, P., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.07.053 · Cited by 33
Circulating spexin levels are influenced by the presence or absence of gestational diabetes
Al‐Daghri, N. M., Sabico, S., Al‐Hazmi, H., Alenad, A. M. H., Al-Amro, A., Alghamdi, A. A., Hussain, S. D., Chrousos, G. P., & Alokail, M. S. (2018) · Cytokine · doi:10.1016/j.cyto.2018.07.023 · Cited by 32
Rivera‐Íñiguez, I., Panduro, A., Ramos-López, O., Villaseñor-Bayardo, S. J., & Román, S. (2018) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-018-0596-9 · Cited by 32
Toi, N., Inaba, M., Kurajoh, M., Morioka, T., Hayashi, N., Hirota, T., Miyaoka, D., Emoto, M., & Yamada, S. (2018) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2018.12.006 · Cited by 32
Cedillo, Y. E., Murillo, A. L., & Fernández, J. R. (2019) · Pediatric Obesity · doi:10.1111/ijpo.12501 · Cited by 32
Castellano, C., Hudon, C., Croteau, É., Fortier, M., St‐Pierre, V., Vandenberghe, C., Nugent, S., Tremblay, S., Paquet, N., Lepage, M., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00015 · Cited by 32
Ortiz-Flores, A. E., Luque‐Ramírez, M., Fernández‐Durán, E., Álvarez‐Blasco, F., & Escobar-Morreale, H. F. (2019) · Metabolism · doi:10.1016/j.metabol.2019.01.015 · Cited by 33
Hong, A. R., Koo, B. K., Kim, S. W., Yi, K. H., & Moon, M. K. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0134 · Cited by 33
Lee, S., Lee, Y., Choi, E., Cho, Y., & Kim, J. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-0741 · Cited by 34
Schumacher-Petersen, C., Christoffersen, B. Ø., Kirk, R. K., Ludvigsen, T. P., Zois, N. E., Pedersen, H. D., Vyberg, M., & Olsen, L. H. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1854-y · Cited by 32
Cain, M. A., Brumley, J., Louis‐Jacques, A. F., Drerup, M. L., Stern, M., & Louis, J. M. (2019) · Behavioral Sleep Medicine · doi:10.1080/15402002.2019.1613995 · Cited by 32
Dai, Z., Feng, S., Liu, A. B., Wang, H., Zeng, X., & Yang, C. S. (2019) · Food & Function · doi:10.1039/c9fo00463g · Cited by 34
Ferreira, Y. A. M., Kravchychyn, A. C. P., Vicente, S. E. D. C. F., Campos, R. M. D. S., Tock, L., Oyama, L. M., Boldarine, V. T., Masquio, D. C. L., Thivel, D., Shivappa, N., et al. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00077 · Cited by 35
Stojek, M. M., Maples‐Keller, J. L., Dixon, H. D., Umpierrez, G. E., Gillespie, C. F., & Michopoulos, V. (2019) · Appetite · doi:10.1016/j.appet.2019.104317 · Cited by 32
Obafemi, T. O., Olaleye, M. T., & Akinmoladun, A. C. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112124 · Cited by 32
Crucial Role of the SH2B1 PH Domain for the Control of Energy Balance
Flores, A., Argetsinger, L. S., Stadler, L. K. J., Malaga, A. E., Vander, P. B., DeSantis, L. C., Joe, R. M., Cline, J. M., Keogh, J. M., Henning, E., et al. (2019) · Diabetes · doi:10.2337/db19-0608 · Cited by 31
Holm, M. R., Christensen, H., Rasmussen, J., Johansen, M. L., Schou, M., Faber, J. O., & Kistorp, C. (2019) · ESC Heart Failure · doi:10.1002/ehf2.12502 · Cited by 32
Kong, X., Xing, X., Zhang, X., Hong, J., & Yang, W. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3214 · Cited by 33
Verkouter, I., Noordam, R., le Cessie, S., van Dam, R. M., Lamb, H. J., Rosendaal, F. R., van Heemst, D., & de Mutsert, R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101559 · Cited by 33
Martínez-García, M. Á., Moncayo, S., Insenser, M. R., Álvarez‐Blasco, F., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2019) · Nutrients · doi:10.3390/nu11112566 · Cited by 32
Balanescu, A., Stan, I. V., Codreanu, I. F., Comănici, V. D., Balanescu, A., & Balanescu, P. C. (2019) · Disease Markers · doi:10.1155/2019/9560247 · Cited by 32
Oshida, N., Shida, T., Oh, S., Kim, T., Isobe, T., Okamoto, Y., Kamimaki, T., Okada, K., Suzuki, H., Ariizumi, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56121-7 · Cited by 32
Plasma metabolic alterations in patients with severe obesity and non‐alcoholic steatohepatitis
Cabré, N., Luciano‐Mateo, F., Baiges‐Gayà, G., Fernández‐Arroyo, S., Rodríguez‐Tomàs, E., Hernández‐Aguilera, A., París, M., Sabench, F., Castillo, D. D., López‐Miranda, J., et al. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15606 · Cited by 32
Soetikno, V., Murwantara, A., Andini, P., et al. (2020) · Journal of Experimental Pharmacology · doi:10.2147/jep.s233111 · Cited by 32
Mosavat, M., Omar, S. Z., Jamalpour, S., & Tan, P. C. (2020) · Journal of Diabetes Research · doi:10.1155/2020/9072492 · Cited by 32
Cordier, S., Anassour-Laouan-Sidi, E., Lemire, M., et al. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109345 · Cited by 32
Gutiérrez, O. M., Porter, A. K., Viggeswarapu, M., Roberts, J. L., & Beck, G. R. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108374 · Cited by 35
Excess serum uric acid is associated with metabolic syndrome in obese adolescent patients
Foster, C., Smith, L., & Alemzadeh, R. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00507-2 · Cited by 33
Wang, Y., Wan, H., Chen, C., Chen, Y., Xia, F., Han, B., Qin, L., Wang, N., & Lu, Y. (2020) · Nutrition and Diabetes · doi:10.1038/s41387-020-0121-x · Cited by 32
Karamzad, N., Faraji, E., Adeli, S., Carson‐Chahhoud, K., Azizi, S., & Gargari, B. P. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s253014 · Cited by 32
Gao, L., Tang, H. Y., Zeng, Q., Tang, T. S., Chen, M., & Pu, P. (2020) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2020.06.005 · Cited by 33
Lionett, S., Kiel, I. A., CAMERA, D. M., Vanky, E., Parr, E. B., Lydersen, S., Hawley, J. A., & Moholdt, T. T. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00904 · Cited by 33
Choromańska, B., Myśliwiec, P., Łuba, M., Wojskowicz, P., Myśliwiec, H., Choromańska, K., Dadan, J., Zalewska, A., & Maciejczyk, M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1057570 · Cited by 32
Vacínová, G., Vejražková, D., Rusina, R., Holmerová, I., Vaňková, H., Jarolímová, E., Včelák, J., Bendlová, B., & Vaňková, M. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.295340 · Cited by 35
Wiggers, H., Køber, L., Gislason, G., Schou, M., Poulsen, M. K., Vraa, S., Nielsen, O. W., Bruun, N. E., Nørrelund, H., Hollingdal, M., et al. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.09.020 · Cited by 33
Habib, H. A., Heeba, G. H., & Khalifa, M. M. A. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173721 · Cited by 33
Kaartinen, M. T., Arora, M., Heinonen, S., Hang, A., Barry, A., Lundbom, J., Hakkarainen, A., Lundholm, N., Rissanen, A., Kaprio, J. A., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-00722-0 · Cited by 33
Franck, M., de Toro‐Martín, J., Garneau, V., Guay, V., Kearney, M., Pilon, G., Roy, D., Couture, P., Couillard, C., Marette, A., et al. (2020) · Nutrients · doi:10.3390/nu12123858 · Cited by 35
Jun, J. E., Kang, H., Hwang, Y., Ahn, K. J., Chung, H.-Y., & Jeong, I. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108622 · Cited by 31
Urrutia, I., Martín-Nieto, A., Martı́nez, R., Marsal, J. O. C., Aguayo, A., del Olmo, J., Arana‐Arri, E., Fernández-Rubio, E., Castaño, L. A., Gaztambide, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82548-y · Cited by 37
Son, W., & Park, J.-J. (2021) · Journal of Sports Science and Medicine · doi:10.52082/jssm.2021.291 · Cited by 34
Yang, Y., Wang, B., Yuan, H., & Li, X. (2021) · International Journal of Endocrinology · doi:10.1155/2021/6676569 · Cited by 32
Berberine Ameliorates Hepatic Insulin Resistance by Regulating microRNA-146b/SIRT1 Pathway
Sui, M., Jiang, X., Sun, H., Liu, C., & Fan, Y. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s313068 · Cited by 32
Izquierdo, A. G., Boughanem, H., Díaz‐Lagares, Á., Arranz‐Salas, I., Esteller, M., Tinahones, F. J., Casanueva, F. F., Macías‐González, M., & Crujeiras, A. B. (2021) · Epigenetics · doi:10.1080/15592294.2021.1950991 · Cited by 33
Effects of age and gender on the redox homeostasis of morbidly obese people
Choromańska, B., Myśliwiec, P., Dadan, J., Maleckas, A., Zalewska, A., & Maciejczyk, M. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.08.009 · Cited by 32
Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease
Jung, I., Lee, W., Lee, M. Y., Kwon, H., Rhee, E., Park, C., Oh, K.-W., Lee, W., Park, S., & Park, S. E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.752944 · Cited by 33
Tavaglione, F., Vincentis, A. D., Bruni, V., Gallo, I. F., Carotti, S., Tuccinardi, D., Spagnolo, G., Ciociola, E., Mancina, R. M., Jamialahmadi, O., et al. (2021) · Liver International · doi:10.1111/liv.15127 · Cited by 32
Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome
Milić, J., Barbieri, S., Gozzi, L., Brigo, A., Beghé, B., Verduri, A., Bacca, E., Iadisernia, V., Cuomo, G., Dolci, G., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac003 · Cited by 33
Armandi, A., Rosso, C., Nicolosi, A., Caviglia, G. P., Abate, M. L., Olivero, A., D’Amato, D., Vernero, M., Gaggini, M., Saracco, G. M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030635 · Cited by 33
Ye, X., Yu, R., Jiang, F., Hou, X., Wei, L., Bao, Y., & Jia, W. (2022) · Diabetes Care · doi:10.2337/dc21-2113 · Cited by 33
Hoseini, R., Rahim, H. A., & Ahmed, J. K. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03645-7 · Cited by 32
Succurro, E., Marini, M. A., Fiorentino, T. V., Perticone, M., Sciacqua, A., Andreozzi, F., & Sesti, G. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110027 · Cited by 33
REDD1 promotes obesity-induced metabolic dysfunction via atypical NF-κB activation
Lee, D., Kim, T., Byeon, J., Park, M., Kim, S., Kim, J., Choi, S., Lee, G., Park, C., Lee, K. W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34110-1 · Cited by 35
Pan, L., Zou, H., Meng, X., Li, D., Li, W., Chen, X., Yang, Y., & Yu, X. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14024 · Cited by 33
Cobayashi, F., Lourenço, B. H., & Cardoso, M. A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160612531 · Cited by 32
Canivell, S., Rebuffat, S. A., Ruano, E. G., Kostov, B., Sisó‐Almirall, A., Novials, A., Ceriello, A., & Gomis, R. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2599 · Cited by 32
Yilmaz, B., Köklü, S., Büyükbayram, H., et al. (2015) · African Health Sciences · doi:10.4314/ahs.v15i3.3 · Cited by 32
Zhang, J., Huang, X., Liao, M., Gao, Y., Tan, A., Yang, X., Zhang, H., Mo, L., Zhang, Y., Lu, Z., et al. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2405 · Cited by 32
Pighon, A., Barsalani, R., Yasari, S., Prud’homme, D., & Lavoie, J.-M. (2010) · Climacteric · doi:10.3109/13697130903009203 · Cited by 32
SIMONE, G. D., Devereux, R. B., Chinali, M., Roman, M. J., Welty, T. K., Lee, E. T., & Howard, B. V. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283050899 · Cited by 33
Caimari, A., Oliver, P., & Palou, A. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.05.008 · Cited by 32
Weinert, L. S., Mastella, L. S., Oppermann, M. L. R., Silveiro, S. P., Guimarães, L. S. P., & Reichelt, A. J. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003069 · Cited by 32
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
